Literature DB >> 1955232

Verrucae treated by levamisole.

M Amer1, Z Tosson, A Soliman, A G Selim, A Salem, A A al-Gendy.   

Abstract

To assess the role of levamisole in treatment of different types of warts, a double-blind study was conducted on 40 patients with different types of warts. Patients were divided into two equal groups, A and B. Group A received levamisole 5 mg/kg body weight on 3 consecutive days every 2 weeks for a period up to 5 months, while patients of group B received placebo for the same period. In group A, 12 patients showed complete cure (60%), two showed partial cure (10%), and the remaining six patients showed no response (30%). In group B, complete cure was achieved only in one case. The higher cure rate was observed in plane and common warts, while plantar warts showed no improvement with levamisole treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955232     DOI: 10.1111/j.1365-4362.1991.tb02624.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Levamisole monotherapy for oral lichen planus.

Authors:  Tai Hyok Won; Se Young Park; Bo Suk Kim; Phil Seung Seo; Seok Don Park
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

Review 2.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

3.  Plantar warts treated with topical adapalene.

Authors:  Ramji Gupta
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

4.  [Juvenile verrucae planae: treatment with imiquimod 5% cream].

Authors:  M Mühlstädt; K Kerschenlohr; E-M Scharrer; W Pfützner; H C Korting
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

5.  Oxidative stress in patients with nongenital warts.

Authors:  Sezai Sasmaz; Ozer Arican; Ergul Belge Kurutas
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

Review 6.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 7.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

Review 8.  Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.

Authors:  Maryam Dadar; Sandip Chakraborty; Kuldeep Dhama; Minakshi Prasad; Rekha Khandia; Sameer Hassan; Ashok Munjal; Ruchi Tiwari; Kumaragurubaran Karthik; Deepak Kumar; Hafiz M N Iqbal; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.